HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 21-APR-15 4ZFC TITLE CRYSTAL STRUCTURE OF AKR1C3 COMPLEXED WITH GLICAZIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDO-KETO REDUCTASE FAMILY 1 MEMBER C3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5,17-BETA-HSD 5,3- COMPND 5 ALPHA-HSD TYPE II,BRAIN,3-ALPHA-HYDROXYSTEROID DEHYDROGENASE TYPE 2, COMPND 6 3-ALPHA-HSD TYPE 2,CHLORDECONE REDUCTASE HOMOLOG HAKRB,DIHYDRODIOL COMPND 7 DEHYDROGENASE 3,DD3,DIHYDRODIOL DEHYDROGENASE TYPE I,HA1753,INDANOL COMPND 8 DEHYDROGENASE,PROSTAGLANDIN F SYNTHASE,PGFS,TESTOSTERONE 17-BETA- COMPND 9 DEHYDROGENASE 5,TRANS-1,2-DIHYDROBENZENE-1,2-DIOL DEHYDROGENASE; COMPND 10 EC: 1.1.1.357,1.1.1.112,1.1.1.188,1.1.1.239,1.1.1.64,1.3.1.20; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS AKR1C3 INHIBITOR, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.ZHAO,X.ZHRNG,X.HU REVDAT 2 20-MAR-24 4ZFC 1 REMARK REVDAT 1 25-NOV-15 4ZFC 0 JRNL AUTH Y.ZHAO,X.ZHENG,H.ZHANG,J.ZHAI,L.ZHANG,C.LI,K.ZENG,Y.CHEN, JRNL AUTH 2 Q.LI,X.HU JRNL TITL IN VITRO INHIBITION OF AKR1CS BY SULPHONYLUREAS AND THE JRNL TITL 2 STRUCTURAL BASIS JRNL REF CHEM.BIOL.INTERACT. V. 240 310 2015 JRNL REFN ISSN 0009-2797 JRNL PMID 26362498 JRNL DOI 10.1016/J.CBI.2015.09.006 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 80.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 43707 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2326 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3244 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.2490 REMARK 3 BIN FREE R VALUE SET COUNT : 185 REMARK 3 BIN FREE R VALUE : 0.2890 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5089 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 140 REMARK 3 SOLVENT ATOMS : 367 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.48000 REMARK 3 B22 (A**2) : -0.69000 REMARK 3 B33 (A**2) : -0.86000 REMARK 3 B12 (A**2) : 0.12000 REMARK 3 B13 (A**2) : -1.75000 REMARK 3 B23 (A**2) : 0.49000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.180 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.158 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.118 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.401 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.929 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5358 ; 0.018 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 5108 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7273 ; 1.938 ; 1.990 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11784 ; 0.899 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 633 ; 6.139 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 244 ;37.847 ;24.057 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 930 ;13.621 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;12.818 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 791 ; 0.107 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6015 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1231 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2538 ; 1.874 ; 1.997 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2537 ; 1.872 ; 1.995 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3169 ; 2.831 ; 2.984 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3170 ; 2.831 ; 2.986 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2820 ; 2.753 ; 2.326 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2821 ; 2.753 ; 2.327 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 4105 ; 4.386 ; 3.355 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 6335 ; 6.056 ;16.836 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 6245 ; 5.923 ;16.689 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4ZFC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 30-APR-15. REMARK 100 THE DEPOSITION ID IS D_1000209153. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-DEC-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : SEALED TUBE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : OXFORD DIFFRACTION ENHANCE ULTRA REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : OXFORD ONYX CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.21 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46034 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 80.368 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11300 REMARK 200 FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.51600 REMARK 200 R SYM FOR SHELL (I) : 0.51600 REMARK 200 FOR SHELL : 0.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15%-20% PEG8000, 100MM MES, 0.14M REMARK 280 NACL, PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 SER A 3 REMARK 465 LYS A 4 REMARK 465 HIS A 5 REMARK 465 ASP A 321 REMARK 465 GLU A 322 REMARK 465 TYR A 323 REMARK 465 ASP B 321 REMARK 465 GLU B 322 REMARK 465 TYR B 323 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 669 O HOH B 680 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 66 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ASP A 71 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 57 1.26 -151.85 REMARK 500 ALA A 157 1.69 -67.38 REMARK 500 PHE A 197 73.74 -166.92 REMARK 500 SER A 221 172.91 73.28 REMARK 500 ARG A 250 -149.99 -136.39 REMARK 500 GLN A 282 1.20 -67.47 REMARK 500 ASN B 57 10.29 -143.92 REMARK 500 LEU B 182 123.87 -38.12 REMARK 500 PHE B 197 80.29 -157.18 REMARK 500 SER B 221 166.79 81.97 REMARK 500 ARG B 250 -151.29 -121.99 REMARK 500 ARG B 301 27.03 -141.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GCZ A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GCZ B 402 DBREF 4ZFC A 1 323 UNP P42330 AK1C3_HUMAN 1 323 DBREF 4ZFC B 1 323 UNP P42330 AK1C3_HUMAN 1 323 SEQRES 1 A 323 MET ASP SER LYS HIS GLN CYS VAL LYS LEU ASN ASP GLY SEQRES 2 A 323 HIS PHE MET PRO VAL LEU GLY PHE GLY THR TYR ALA PRO SEQRES 3 A 323 PRO GLU VAL PRO ARG SER LYS ALA LEU GLU VAL THR LYS SEQRES 4 A 323 LEU ALA ILE GLU ALA GLY PHE ARG HIS ILE ASP SER ALA SEQRES 5 A 323 HIS LEU TYR ASN ASN GLU GLU GLN VAL GLY LEU ALA ILE SEQRES 6 A 323 ARG SER LYS ILE ALA ASP GLY SER VAL LYS ARG GLU ASP SEQRES 7 A 323 ILE PHE TYR THR SER LYS LEU TRP SER THR PHE HIS ARG SEQRES 8 A 323 PRO GLU LEU VAL ARG PRO ALA LEU GLU ASN SER LEU LYS SEQRES 9 A 323 LYS ALA GLN LEU ASP TYR VAL ASP LEU TYR LEU ILE HIS SEQRES 10 A 323 SER PRO MET SER LEU LYS PRO GLY GLU GLU LEU SER PRO SEQRES 11 A 323 THR ASP GLU ASN GLY LYS VAL ILE PHE ASP ILE VAL ASP SEQRES 12 A 323 LEU CYS THR THR TRP GLU ALA MET GLU LYS CYS LYS ASP SEQRES 13 A 323 ALA GLY LEU ALA LYS SER ILE GLY VAL SER ASN PHE ASN SEQRES 14 A 323 ARG ARG GLN LEU GLU MET ILE LEU ASN LYS PRO GLY LEU SEQRES 15 A 323 LYS TYR LYS PRO VAL CYS ASN GLN VAL GLU CYS HIS PRO SEQRES 16 A 323 TYR PHE ASN ARG SER LYS LEU LEU ASP PHE CYS LYS SER SEQRES 17 A 323 LYS ASP ILE VAL LEU VAL ALA TYR SER ALA LEU GLY SER SEQRES 18 A 323 GLN ARG ASP LYS ARG TRP VAL ASP PRO ASN SER PRO VAL SEQRES 19 A 323 LEU LEU GLU ASP PRO VAL LEU CYS ALA LEU ALA LYS LYS SEQRES 20 A 323 HIS LYS ARG THR PRO ALA LEU ILE ALA LEU ARG TYR GLN SEQRES 21 A 323 LEU GLN ARG GLY VAL VAL VAL LEU ALA LYS SER TYR ASN SEQRES 22 A 323 GLU GLN ARG ILE ARG GLN ASN VAL GLN VAL PHE GLU PHE SEQRES 23 A 323 GLN LEU THR ALA GLU ASP MET LYS ALA ILE ASP GLY LEU SEQRES 24 A 323 ASP ARG ASN LEU HIS TYR PHE ASN SER ASP SER PHE ALA SEQRES 25 A 323 SER HIS PRO ASN TYR PRO TYR SER ASP GLU TYR SEQRES 1 B 323 MET ASP SER LYS HIS GLN CYS VAL LYS LEU ASN ASP GLY SEQRES 2 B 323 HIS PHE MET PRO VAL LEU GLY PHE GLY THR TYR ALA PRO SEQRES 3 B 323 PRO GLU VAL PRO ARG SER LYS ALA LEU GLU VAL THR LYS SEQRES 4 B 323 LEU ALA ILE GLU ALA GLY PHE ARG HIS ILE ASP SER ALA SEQRES 5 B 323 HIS LEU TYR ASN ASN GLU GLU GLN VAL GLY LEU ALA ILE SEQRES 6 B 323 ARG SER LYS ILE ALA ASP GLY SER VAL LYS ARG GLU ASP SEQRES 7 B 323 ILE PHE TYR THR SER LYS LEU TRP SER THR PHE HIS ARG SEQRES 8 B 323 PRO GLU LEU VAL ARG PRO ALA LEU GLU ASN SER LEU LYS SEQRES 9 B 323 LYS ALA GLN LEU ASP TYR VAL ASP LEU TYR LEU ILE HIS SEQRES 10 B 323 SER PRO MET SER LEU LYS PRO GLY GLU GLU LEU SER PRO SEQRES 11 B 323 THR ASP GLU ASN GLY LYS VAL ILE PHE ASP ILE VAL ASP SEQRES 12 B 323 LEU CYS THR THR TRP GLU ALA MET GLU LYS CYS LYS ASP SEQRES 13 B 323 ALA GLY LEU ALA LYS SER ILE GLY VAL SER ASN PHE ASN SEQRES 14 B 323 ARG ARG GLN LEU GLU MET ILE LEU ASN LYS PRO GLY LEU SEQRES 15 B 323 LYS TYR LYS PRO VAL CYS ASN GLN VAL GLU CYS HIS PRO SEQRES 16 B 323 TYR PHE ASN ARG SER LYS LEU LEU ASP PHE CYS LYS SER SEQRES 17 B 323 LYS ASP ILE VAL LEU VAL ALA TYR SER ALA LEU GLY SER SEQRES 18 B 323 GLN ARG ASP LYS ARG TRP VAL ASP PRO ASN SER PRO VAL SEQRES 19 B 323 LEU LEU GLU ASP PRO VAL LEU CYS ALA LEU ALA LYS LYS SEQRES 20 B 323 HIS LYS ARG THR PRO ALA LEU ILE ALA LEU ARG TYR GLN SEQRES 21 B 323 LEU GLN ARG GLY VAL VAL VAL LEU ALA LYS SER TYR ASN SEQRES 22 B 323 GLU GLN ARG ILE ARG GLN ASN VAL GLN VAL PHE GLU PHE SEQRES 23 B 323 GLN LEU THR ALA GLU ASP MET LYS ALA ILE ASP GLY LEU SEQRES 24 B 323 ASP ARG ASN LEU HIS TYR PHE ASN SER ASP SER PHE ALA SEQRES 25 B 323 SER HIS PRO ASN TYR PRO TYR SER ASP GLU TYR HET NAP A 401 48 HET GCZ A 402 22 HET NAP B 401 48 HET GCZ B 402 22 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM GCZ N-[(3AR,6AS)-HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)- HETNAM 2 GCZ YLCARBAMOYL]-4-METHYLBENZENESULFONAMIDE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN GCZ GLICLAZIDE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 GCZ 2(C15 H21 N3 O3 S) FORMUL 7 HOH *367(H2 O) HELIX 1 AA1 ARG A 31 GLY A 45 1 15 HELIX 2 AA2 ALA A 52 ASN A 56 5 5 HELIX 3 AA3 ASN A 57 ASP A 71 1 15 HELIX 4 AA4 LYS A 75 ILE A 79 5 5 HELIX 5 AA5 TRP A 86 HIS A 90 5 5 HELIX 6 AA6 ARG A 91 GLU A 93 5 3 HELIX 7 AA7 LEU A 94 GLN A 107 1 14 HELIX 8 AA8 ASP A 143 ALA A 157 1 15 HELIX 9 AA9 ASN A 169 ASN A 178 1 10 HELIX 10 AB1 ARG A 199 LYS A 209 1 11 HELIX 11 AB2 VAL A 234 GLU A 237 5 4 HELIX 12 AB3 ASP A 238 LYS A 249 1 12 HELIX 13 AB4 THR A 251 ARG A 263 1 13 HELIX 14 AB5 ASN A 273 GLN A 282 1 10 HELIX 15 AB6 VAL A 283 PHE A 286 5 4 HELIX 16 AB7 THR A 289 GLY A 298 1 10 HELIX 17 AB8 SER A 308 HIS A 314 1 7 HELIX 18 AB9 ARG B 31 GLY B 45 1 15 HELIX 19 AC1 ALA B 52 ASN B 56 5 5 HELIX 20 AC2 ASN B 57 ASP B 71 1 15 HELIX 21 AC3 LYS B 75 ILE B 79 5 5 HELIX 22 AC4 TRP B 86 HIS B 90 5 5 HELIX 23 AC5 ARG B 91 GLN B 107 1 17 HELIX 24 AC6 ASP B 143 ALA B 157 1 15 HELIX 25 AC7 ASN B 169 ASN B 178 1 10 HELIX 26 AC8 ARG B 199 LYS B 209 1 11 HELIX 27 AC9 VAL B 234 GLU B 237 5 4 HELIX 28 AD1 ASP B 238 LYS B 249 1 12 HELIX 29 AD2 THR B 251 ARG B 263 1 13 HELIX 30 AD3 ASN B 273 VAL B 281 1 9 HELIX 31 AD4 GLN B 282 PHE B 286 5 5 HELIX 32 AD5 THR B 289 GLY B 298 1 10 HELIX 33 AD6 SER B 308 SER B 313 1 6 SHEET 1 AA1 2 CYS A 7 LYS A 9 0 SHEET 2 AA1 2 PHE A 15 PRO A 17 -1 O MET A 16 N VAL A 8 SHEET 1 AA2 9 LEU A 19 GLY A 22 0 SHEET 2 AA2 9 HIS A 48 ASP A 50 1 O ASP A 50 N PHE A 21 SHEET 3 AA2 9 PHE A 80 LEU A 85 1 O PHE A 80 N ILE A 49 SHEET 4 AA2 9 VAL A 111 ILE A 116 1 O LEU A 115 N LEU A 85 SHEET 5 AA2 9 ALA A 160 SER A 166 1 O LYS A 161 N VAL A 111 SHEET 6 AA2 9 CYS A 188 GLU A 192 1 O CYS A 188 N VAL A 165 SHEET 7 AA2 9 VAL A 212 TYR A 216 1 O TYR A 216 N VAL A 191 SHEET 8 AA2 9 VAL A 266 LYS A 270 1 O VAL A 266 N ALA A 215 SHEET 9 AA2 9 LEU A 19 GLY A 22 1 N GLY A 20 O VAL A 267 SHEET 1 AA3 2 CYS B 7 LYS B 9 0 SHEET 2 AA3 2 PHE B 15 PRO B 17 -1 O MET B 16 N VAL B 8 SHEET 1 AA4 9 LEU B 19 GLY B 22 0 SHEET 2 AA4 9 HIS B 48 ASP B 50 1 O HIS B 48 N PHE B 21 SHEET 3 AA4 9 PHE B 80 LEU B 85 1 O PHE B 80 N ILE B 49 SHEET 4 AA4 9 VAL B 111 ILE B 116 1 O LEU B 115 N LEU B 85 SHEET 5 AA4 9 ALA B 160 SER B 166 1 O GLY B 164 N TYR B 114 SHEET 6 AA4 9 CYS B 188 GLU B 192 1 O CYS B 188 N VAL B 165 SHEET 7 AA4 9 VAL B 212 TYR B 216 1 O VAL B 214 N VAL B 191 SHEET 8 AA4 9 VAL B 266 LYS B 270 1 O VAL B 266 N ALA B 215 SHEET 9 AA4 9 LEU B 19 GLY B 22 1 N GLY B 20 O VAL B 267 SITE 1 AC1 31 GLY A 22 THR A 23 TYR A 24 ASP A 50 SITE 2 AC1 31 TYR A 55 LYS A 84 HIS A 117 SER A 166 SITE 3 AC1 31 ASN A 167 GLN A 190 TYR A 216 SER A 217 SITE 4 AC1 31 ALA A 218 LEU A 219 GLY A 220 SER A 221 SITE 5 AC1 31 GLN A 222 ALA A 253 LEU A 268 ALA A 269 SITE 6 AC1 31 LYS A 270 SER A 271 TYR A 272 ARG A 276 SITE 7 AC1 31 GLN A 279 ASN A 280 GCZ A 402 HOH A 518 SITE 8 AC1 31 HOH A 542 HOH A 576 HOH A 620 SITE 1 AC2 10 TYR A 24 LEU A 54 TYR A 55 HIS A 117 SITE 2 AC2 10 MET A 120 ASN A 167 TRP A 227 PHE A 306 SITE 3 AC2 10 NAP A 401 HOH A 533 SITE 1 AC3 33 GLY B 22 THR B 23 TYR B 24 ASP B 50 SITE 2 AC3 33 TYR B 55 LYS B 84 HIS B 117 SER B 166 SITE 3 AC3 33 ASN B 167 GLN B 190 TYR B 216 SER B 217 SITE 4 AC3 33 ALA B 218 LEU B 219 GLY B 220 SER B 221 SITE 5 AC3 33 GLN B 222 ALA B 253 LEU B 268 ALA B 269 SITE 6 AC3 33 LYS B 270 SER B 271 TYR B 272 ARG B 276 SITE 7 AC3 33 GLN B 279 ASN B 280 GCZ B 402 HOH B 513 SITE 8 AC3 33 HOH B 518 HOH B 532 HOH B 551 HOH B 581 SITE 9 AC3 33 HOH B 637 SITE 1 AC4 9 TYR B 24 LEU B 54 TYR B 55 HIS B 117 SITE 2 AC4 9 ASN B 167 TRP B 227 PHE B 306 NAP B 401 SITE 3 AC4 9 HOH B 526 CRYST1 47.652 49.156 83.476 74.52 86.84 69.09 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020986 -0.008018 0.001001 0.00000 SCALE2 0.000000 0.021778 -0.005986 0.00000 SCALE3 0.000000 0.000000 0.012443 0.00000